9CV2
Crystal structure of the metallo-beta-lactamase VIM-20 with D-captopril
9CV2 の概要
| エントリーDOI | 10.2210/pdb9cv2/pdb |
| 分子名称 | Metallo-beta-lactamase VIM-20, ZINC ION, 1-(3-MERCAPTO-2-METHYL-PROPIONYL)-PYRROLIDINE-2-CARBOXYLIC ACID, ... (4 entities in total) |
| 機能のキーワード | metallo-beta-lactamase, hydrolase |
| 由来する生物種 | Enterobacter cloacae |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 26298.28 |
| 構造登録者 | |
| 主引用文献 | Silwal, S.B.,Wamsley, B.,Wang, Z.,Gung, B.W.,Nix, J.C.,Page, R.C. Mutation of an active site-adjacent residue in VIM indirectly dictates interactions with and blunts inhibition by D-captopril. J.Inorg.Biochem., 271:112975-112975, 2025 Cited by PubMed Abstract: Activity assays and X-ray crystallographic studies were undertaken to elucidate the inhibitory mechanism of captopril stereoisomers on Verona integron-encoded metallo-β-lactamases, specifically VIM-20, VIM-31, and VIM-15. All three VIM-2-like variants (VIM-20, VIM-31, and VIM-15) and VIM-2 expressed in Escherichia coli exhibited catalytic activity with comparable steady-state kinetic parameters. Among the tested thiol drugs (L- and D-captopril, D,L-thiorphan, and 2,3-dimercaprol), IC analyses indicated that D-captopril and 2,3-dimercaprol were more potent inhibitors against the VIM enzymes examined in this study. Notably, the IC value of D-captopril against VIM-31 was an exception, closely resembling that of L-captopril. To elucidate this exceptional inhibitory potency of D-captopril and its binding mode in the active site of VIM-31, high-resolution crystal structures of VIM-20, VIM-31, and VIM-15 in complex with both L- and D-captopril are reported. These findings will help evaluate whether the identified potent inhibitor D-captopril could be further developed as a pan inhibitor targeting the VIM-family enzymes. PubMed: 40513263DOI: 10.1016/j.jinorgbio.2025.112975 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.57 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






